You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

thrombocythemia myelofibrosis

Showing 1 - 25 of 412
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Real World Evidence of Fedratinib Effectiveness in MF

Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
May 22, 2023

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

    Terminated
    • Primary Myelofibrosis (PMF)
    • +2 more
    • Larkspur, California
    • +2 more
    Nov 14, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

    Recruiting
    • Primary Myelofibrosis
    • +4 more
    • New York, New York
      Ruttenberg Treatment Center
    Jul 18, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Worcester, Massachusetts
    • +16 more
    Oct 31, 2022

    Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

    Recruiting
    • Myelofibrosis; Anemia
    • +5 more
    • Jacksonville, Florida
    • +6 more
    Jan 3, 2023

    Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

    Recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablet
    • Canton, Ohio
      Site 01
    Aug 18, 2022

    Primary Myelofibrosis Trial in Japan (Fedratinib)

    Recruiting
    • Primary Myelofibrosis
    • Suwa, Nagano, Japan
    • +25 more
    Jan 18, 2023

    Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

    Recruiting
    • Myelofibrosis Due to and Following Polycythemia Vera
    • Basking Ridge, New Jersey
    • +6 more
    Jan 26, 2023

    Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), Thrombocythemia Myelofibrosis (PET-MF) Trial

    Available
    • Primary Myelofibrosis (PMF)
    • +2 more
    • (no location specified)
    Jan 18, 2022

    Myelofibrosis Trial in Worldwide (PXS-5505)

    Recruiting
    • Myelofibrosis
    • Birmingham, Alabama
    • +19 more
    Nov 28, 2022

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    Feb 10, 2022

    Myelofibrosis, Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) Trial in

    Completed
    • Myelofibrosis
    • +3 more
    • Ann Arbor, Michigan
    • +4 more
    Mar 28, 2022

    A Prospective, Two-arm, Non-interventional Study of JAKAVI® in

    Active, not recruiting
    • Primary Myelofibrosis
    • +2 more
    • Jakavi
    • Aachen, Germany
      Novartis Investigative Site
    Sep 6, 2021

    Idiopathic Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia-Vera Myelofibrosis Trial in Worldwide

    Completed
    • Idiopathic Myelofibrosis
    • +2 more
    • Paris, France
    • +9 more
    Jun 22, 2021

    Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Polycythemia Vera, Essential Thrombocythemia, and

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Next-generation sequencing
    • (no location specified)
    Jun 27, 2022

    Myelofibrosis Trial in Worldwide (Ruxolitinib)

    Completed
    Has Results
    • Myelofibrosis
    • Winter Park, Florida
    • +17 more
    Jan 10, 2022

    Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

    Not yet recruiting
    • Myeloproliferative Disorders
    • +3 more
    • (no location specified)
    Nov 21, 2023

    Myeloproliferative Tumor, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial (CALR allele burden

    Recruiting
    • Myeloproliferative Neoplasm
    • +3 more
    • CALR allele burden quantification
    • Angers, France
      CHU Angers
    Nov 2, 2022

    Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

    Active, not recruiting
    • Myeloproliferative Neoplasm
    • +4 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Jan 6, 2023

    Myelofibrosis, Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Jaktinib hydrochloride tablets
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Medical School of Zhejiang Univ
    Jun 11, 2021

    Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

    Active, not recruiting
    • Myelofibrosis
    • +2 more
    • New Orleans, Louisiana
    • +20 more
    Aug 25, 2022